Cargando…
COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652043/ https://www.ncbi.nlm.nih.gov/pubmed/36369623 http://dx.doi.org/10.1007/s42000-022-00419-1 |
| _version_ | 1784828378655752192 |
|---|---|
| author | Paschou, Stavroula A. Karalis, Vangelis Psaltopoulou, Theodora Charitaki, Ioanna Sklirou, Aimilia D. Iconomidou, Vassiliki A. Vasileiou, Vasiliki Kassi, Georgia N. Vryonidou, Andromachi Kokkinos, Alexander Tentolouris, Nicholas Hatziaggelaki, Erifili Trougakos, Ioannis P. Terpos, Evangelos Dimopoulos, Meletios-Athanasios |
| author_facet | Paschou, Stavroula A. Karalis, Vangelis Psaltopoulou, Theodora Charitaki, Ioanna Sklirou, Aimilia D. Iconomidou, Vassiliki A. Vasileiou, Vasiliki Kassi, Georgia N. Vryonidou, Andromachi Kokkinos, Alexander Tentolouris, Nicholas Hatziaggelaki, Erifili Trougakos, Ioannis P. Terpos, Evangelos Dimopoulos, Meletios-Athanasios |
| author_sort | Paschou, Stavroula A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9652043 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96520432022-11-14 COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus Paschou, Stavroula A. Karalis, Vangelis Psaltopoulou, Theodora Charitaki, Ioanna Sklirou, Aimilia D. Iconomidou, Vassiliki A. Vasileiou, Vasiliki Kassi, Georgia N. Vryonidou, Andromachi Kokkinos, Alexander Tentolouris, Nicholas Hatziaggelaki, Erifili Trougakos, Ioannis P. Terpos, Evangelos Dimopoulos, Meletios-Athanasios Hormones (Athens) Letter to the Editor Springer International Publishing 2022-11-11 2023 /pmc/articles/PMC9652043/ /pubmed/36369623 http://dx.doi.org/10.1007/s42000-022-00419-1 Text en © The Author(s), under exclusive licence to Hellenic Endocrine Society 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Paschou, Stavroula A. Karalis, Vangelis Psaltopoulou, Theodora Charitaki, Ioanna Sklirou, Aimilia D. Iconomidou, Vassiliki A. Vasileiou, Vasiliki Kassi, Georgia N. Vryonidou, Andromachi Kokkinos, Alexander Tentolouris, Nicholas Hatziaggelaki, Erifili Trougakos, Ioannis P. Terpos, Evangelos Dimopoulos, Meletios-Athanasios COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus |
| title | COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus |
| title_full | COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus |
| title_fullStr | COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus |
| title_full_unstemmed | COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus |
| title_short | COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus |
| title_sort | covid-19 bnt162b2 mrna vaccine for patients with type 2 diabetes mellitus |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652043/ https://www.ncbi.nlm.nih.gov/pubmed/36369623 http://dx.doi.org/10.1007/s42000-022-00419-1 |
| work_keys_str_mv | AT paschoustavroulaa covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT karalisvangelis covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT psaltopouloutheodora covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT charitakiioanna covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT sklirouaimiliad covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT iconomidouvassilikia covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT vasileiouvasiliki covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT kassigeorgian covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT vryonidouandromachi covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT kokkinosalexander covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT tentolourisnicholas covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT hatziaggelakierifili covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT trougakosioannisp covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT terposevangelos covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus AT dimopoulosmeletiosathanasios covid19bnt162b2mrnavaccineforpatientswithtype2diabetesmellitus |